|
orofaciodigital syndrome
|
DOID_4501 |
|
|
hypokalemia
|
DOID_4500 |
|
|
mineral metabolism disease
|
DOID_0050032 |
|
|
spermatocytoma
|
DOID_5834 |
|
|
subvalvular aortic stenosis
|
DOID_5805 |
|
|
aortic valve stenosis
|
DOID_1712 |
|
|
discrete subaortic stenosis
|
DOID_5804 |
|
|
5-hydroxytryptamine 2A receptor inverse agonist
|
CHEBI_133016 |
|
|
inverse agonist
|
CHEBI_90847 |
|
|
intracranial aneurysm
|
DOID_10941 |
|
|
cerebral arterial disease
|
DOID_3527 |
|
|
tongue disease
|
DOID_10944 |
|
|
EC 3.5.4.4 (adenosine deaminase) inhibitor
|
CHEBI_50445 |
|
|
EC 3.5.4.* (non-peptide cyclic amidine C-N hydrolase) inhibitor
|
CHEBI_76809 |
|
|
adenosine phosphodiesterase inhibitor
|
CHEBI_50444 |
|
|
nematicide
|
CHEBI_25491 |
|
|
lymphocyte function-associated antigen-1 antagonist
|
CHEBI_133024 |
|
|
signaling receptor binding
|
GO_0005102 |
|
|
protein binding
|
GO_0005515 |
|
|
nephritis
|
DOID_10952 |
|
